Maraviroc in kids

Project no.: HIV-NAT 156

An open-label, multicenter, multiple-dose pharmacokinetic, safety and efficacy trial of maraviroc in combination with optimized background therapy for the treatment of antiretrovival-experienced CCR-5 tropic HIV-1 infected children 2 -< 18

The study will evaluate the efficacy and safety of maraviroc in HIV-infected children.